Dulaglutide Market Overview 2024-2033 – Competitive Landscape and Strategies

The Dulaglutide Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Dulaglutide Market:
https://www.thebusinessresearchcompany.com/report/dulaglutide-global-market-report

According to The Business Research Company’s Dulaglutide Global Market Report 2024, The dulaglutide market size has grown strongly in recent years. It will grow from $3.87 billion in 2023 to $4.17 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to the increasing prevalence of type 2 diabetes, increasing utilization, increasing research and development investments, increased focus on chronic diseases, and growth in personalized medicine.

The dulaglutide market size is expected to see strong growth in the next few years. It will grow to $5.66 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to increasing clinical trials, rising obesity rates, rising aging population, growing telemedicine services, growing endocrinology clinics, and growing use of electronic health records. Major trends in the forecast period include technological advancements, personalized medicine, telemedicine, digital health platforms, and mobile health apps.

The increasing prevalence of type 2 diabetes is expected to propel the growth of the dulaglutide market going forward. Type 2 diabetes is a chronic condition where the body becomes resistant to insulin or doesn’t produce enough insulin, leading to elevated blood sugar levels. The increase in type 2 diabetes is due to rising rates of obesity, poor diets, and sedentary lifestyles. Dulaglutide helps manage type 2 diabetes by enhancing insulin secretion and reducing glucagon levels in response to food intake, which lowers blood sugar levels. For instance, in December 2021, according to the International Diabetes Federation, a US-based intergovernmental organization, diabetes affected 537 million adults aged 20 to 79 in 2021, with that figure anticipated to rise to 643 million by 2030 and 783 million by 2045. Therefore, the increasing prevalence of type 2 diabetes is driving the growth of the dulaglutide market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18338&type=smp

The dulaglutide market covered in this report is segmented –

1) By Type: Syringe Pen, Multi-Dose Bottles
2) By Application: Medical Insurance, Pharmaceutical, Clinical Research
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Major companies operating in the dulaglutide market are focused on developing innovative products, such as anti-diabetic drugs, to meet the increasing demand for effective treatments for managing diabetes mellitus. Anti-diabetic drugs are medications that manage and treat diabetes mellitus by regulating blood sugar levels through mechanisms like increasing insulin sensitivity, stimulating insulin production, or slowing glucose absorption from the digestive tract. For instance, in January 2024, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched the first biosimilar of the anti-diabetic drug Liraglutide in India under the brand name Lirafit. This move signifies Glenmark’s strategic entry into the biosimilar market for anti-diabetic drugs, aimed at providing patients with a more affordable treatment option. The biosimilar is expected to maintain efficacy and safety profiles comparable to the original drug, meeting stringent regulatory standards.

The dulaglutide market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model